CPhI is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Unlock the future of pharma

The 2023 CPHI Annual Report

Discover fascinating insights from over 250 global industry leaders that illuminate anticipated industry trends in 2024. And dive into a detailed analysis of major pharma markets on various vital metrics.

Plus, gain the visionary perspectives of global experts shaping the industry today and forecasting the trends of tomorrow. This includes key voices from Pharmatech Associates, Vertex Pharmaceuticals, Edgewater Capital Partners, Pharma and Biopharma Outsourcing Association, GlobalData, BioProcess Technology Group, BioPlan Associates, Ysios Capital and Sirio Europe.

Highlights include...

  • How AI will transform drug discovery and pharma manufacturing processes by 2026

  • The market outlook for CDMOs in 2024 and beyond

  • An overview of prospects in the fast-growing Chinese biopharma sector 

  • An in-depth analysis of the Spanish biotech sector – with Barcelona recently voted Europe’s second-best biotech investment hub in the annual CPHI survey 

  • A detailed analysis of private equity funding, VC pipelines and the consequential impact for contract services 

  • Predictions on how PAT developments will revolutionise manufacturing 

  • Nutraceutical trends in 2024 and the rise of personalised nutrition as complementary product class 

  • What sustainability means for biopharma production 
Person holding computer tablet displaying Pharma annual report